Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 2,470 | 4,630 | 3,460 | 4,460 | 2,340 |
| TOTAL | $2,470 | $4,630 | $3,460 | $4,460 | $2,340 |
| Non-Current Assets | |||||
| PPE Net | 14,830 | N/A | N/A | N/A | N/A |
| Investments And Advances | 6,180 | 5,430 | 5,430 | 2,710 | 1,900 |
| Other Non-Current Assets | 460 | 540 | 540 | 15,720 | 16,540 |
| TOTAL | $21,470 | $5,970 | $5,970 | $18,430 | $18,440 |
| Total Assets | $23,940 | $10,600 | $9,430 | $22,890 | $20,780 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,200 | 20,320 | 19,860 | 17,050 | 5,430 |
| Accrued Expenses | 12,780 | 0 | 0 | 0 | 13,060 |
| Other current liabilities | 17,160 | 16,140 | 18,090 | 14,030 | 14,810 |
| TOTAL | $34,140 | $36,460 | $37,950 | $31,080 | $33,300 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 1,020 | 1,000 | 980 | 3,130 |
| TOTAL | $1,690 | $4,540 | $4,280 | $2,920 | $4,730 |
| Total Liabilities | $35,830 | $41,000 | $42,230 | $34,000 | $38,030 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Other shareholders' equity | -10 | -160 | -168 | -30 | -20 |
| TOTAL | $74,560 | $73,960 | $73,952 | $73,690 | $74,700 |
| Total Liabilities And Equity | $110,390 | $114,960 | $116,182 | $107,690 | $112,730 |